Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
- Published In:
- Frontiers in immunology, 10, 1505 (2019)
- Authors:
- Leclerc, Marine, Mezquita, Laura, Guillebot De Nerville, Guillaume, Tihy, Isabelle, Malenica, Ines, Chouaib, Salem, Mami-Chouaib, Fathia
- Database ID:
- RPEP-04307
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04307APA
Leclerc, Marine; Mezquita, Laura; Guillebot De Nerville, Guillaume; Tihy, Isabelle; Malenica, Ines; Chouaib, Salem; Mami-Chouaib, Fathia. (2019). Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.. Frontiers in immunology, 10, 1505. https://doi.org/10.3389/fimmu.2019.01505
MLA
Leclerc, Marine, et al. "Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.." Frontiers in immunology, 2019. https://doi.org/10.3389/fimmu.2019.01505
RethinkPeptides
RethinkPeptides Research Database. "Recent Advances in Lung Cancer Immunotherapy: Input of T-Cel..." RPEP-04307. Retrieved from https://rethinkpeptides.com/research/leclerc-2019-recent-advances-in-lung
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.